Treating the patient and not just the cancer: therapeutic burden in prostate cancer.
Daniel E SprattNeal ShoreA Oliver SartorDana RathkopfKara OlivierPublished in: Prostate cancer and prostatic diseases (2021)
As the treatment landscape in PC continues to rapidly evolve, consideration must be given to the balance between therapeutic benefits and potential treatment-emergent adverse events that may be further complicated by DDIs with concomitant medications. Patient-centered communication is a crucial aspect of alleviating this burden, and healthcare professionals (HCPs) may benefit from training in effective patient communication. HCPs should closely and frequently monitor patient treatment responses, in order to better understand symptom onset and exacerbation. Patients also should be encouraged to participate in exercise programs, and health information and support groups, which may assist them in preventing or mitigating certain determinants of the therapeutic burden associated with PC and its management.
Keyphrases
- prostate cancer
- health information
- case report
- end stage renal disease
- chronic kidney disease
- chronic obstructive pulmonary disease
- social media
- squamous cell carcinoma
- risk factors
- public health
- intensive care unit
- climate change
- healthcare
- prognostic factors
- lymph node metastasis
- peritoneal dialysis
- patient reported outcomes
- resistance training
- mechanical ventilation
- squamous cell
- human health
- extracorporeal membrane oxygenation